Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Double Blind Controlled Trial for the Treatment of Nucleic Acid Amplification Test (NAAT)+/Toxin Enzyme Immunoassay (EIA)- Clostridium Difficile in the Hematology Oncology Population

NCT03030248 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT03030248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03030248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Double Blind Controlled Trial for the Treatment of Nucleic Acid Amplification Test (NAAT)+/Toxin Enzyme Immunoassay (EIA)- Clostridium Difficile in the Hematology Oncology Population
Lead sponsor
Medical College of Wisconsin
Phase
Phase 2
Overall status
Completed
Start date
June 1, 2018
Completion date
June 30, 2020
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone marrow transplant, clostridium difficile infection, hematologic diseases, oncologic disorders